Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share (PTGX).
- Disclosed ownership: 4.1%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 4.1% ownership in Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share (PTGX) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.1% | 1,323,333 | 0 | 1,323,333 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.1% | 1,323,333 | 0 | 1,323,333 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.7% | 1,045,774 | 0 | 1,045,774 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.7% | 1,045,774 | 0 | 1,045,774 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.2% | 140,917 | 0 | 140,917 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.2% | 140,917 | 0 | 140,917 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 3.8% | 2,369,107 | 0 | 2,369,107 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 4.1% | 2,560,916 | 0 | 2,560,916 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 4.1% | 2,560,916 | 0 | 2,560,916 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 4.1% | 2,560,916 | 0 | 2,560,916 | /s/ Mark N. Lampert | Mark N. Lampert |